Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127756991 | 12775699 | 1 | I | 20150303 | 20160913 | 20160923 | 20160923 | EXP | US-JNJFOC-20160923387 | JANSSEN | 72.00 | YR | E | M | Y | 99.00000 | KG | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127756991 | 12775699 | 1 | PS | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | Y | N | 20281 | 50 | MG | UNSPECIFIED | TID | |||||
| 127756991 | 12775699 | 2 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
| 127756991 | 12775699 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | Y | 0 | 100 | MG | UNSPECIFIED | TID | ||||||
| 127756991 | 12775699 | 4 | SS | HYDROCODONE | HYDROCODONE | 1 | Oral | Y | 0 | UNSPECIFIED | |||||||||
| 127756991 | 12775699 | 5 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | D | 0 | TABLET | |||||||||
| 127756991 | 12775699 | 6 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | D | 0 | TABLET | |||||||||
| 127756991 | 12775699 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 127756991 | 12775699 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 127756991 | 12775699 | 9 | C | MORPHINE | MORPHINE | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 127756991 | 12775699 | 10 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | D | 0 | UNSPECIFIED | |||||||||
| 127756991 | 12775699 | 11 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | Oral | D | 0 | 5 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127756991 | 12775699 | 1 | Arthralgia |
| 127756991 | 12775699 | 2 | Procedural pain |
| 127756991 | 12775699 | 3 | Neuropathy peripheral |
| 127756991 | 12775699 | 4 | Procedural pain |
| 127756991 | 12775699 | 5 | Rheumatoid arthritis |
| 127756991 | 12775699 | 6 | Osteoarthritis |
| 127756991 | 12775699 | 7 | Dyslipidaemia |
| 127756991 | 12775699 | 8 | Insulin resistance |
| 127756991 | 12775699 | 9 | Back pain |
| 127756991 | 12775699 | 10 | Anxiety |
| 127756991 | 12775699 | 11 | Hypertonic bladder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127756991 | 12775699 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127756991 | 12775699 | Fall | |
| 127756991 | 12775699 | Mental status changes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127756991 | 12775699 | 1 | 20131205 | 20150304 | 0 | |
| 127756991 | 12775699 | 2 | 20150225 | 20150303 | 0 | |
| 127756991 | 12775699 | 3 | 2009 | 20150304 | 0 | |
| 127756991 | 12775699 | 4 | 20150225 | 20150303 | 0 | |
| 127756991 | 12775699 | 5 | 20120906 | 20130328 | 0 | |
| 127756991 | 12775699 | 6 | 20120906 | 20130328 | 0 | |
| 127756991 | 12775699 | 7 | 201412 | 0 | ||
| 127756991 | 12775699 | 8 | 2009 | 0 | ||
| 127756991 | 12775699 | 9 | 20110902 | 0 | ||
| 127756991 | 12775699 | 10 | 20140616 | 0 | ||
| 127756991 | 12775699 | 11 | 20140510 | 0 |